Page last updated: 2024-10-31

mitoxantrone and Cutaneous T-Cell Lymphoma

mitoxantrone has been researched along with Cutaneous T-Cell Lymphoma in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
"Subcutaneous panniculitis-like T-cell lymphoma (SCPTCL) is a rare cutaneous T-cell lymphoma."1.31Aggressive subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine, mitoxantrone and dexamethasone. ( Au, WY; Choy, C; Kwong, YL; Ng, WM, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Au, WY1
Ng, WM1
Choy, C1
Kwong, YL1

Other Studies

1 other study available for mitoxantrone and Cutaneous T-Cell Lymphoma

ArticleYear
Aggressive subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine, mitoxantrone and dexamethasone.
    The British journal of dermatology, 2000, Volume: 143, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Follow-Up Studies; Hum

2000